Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-074964

Chief Executive Officer sold 47,775 shares at $20.03 ($956,933)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2026-07-01 Sale 10b5-1 −47,775 $20.03 $956,933 2,877,118 D: show line 1 in the form
Open-market sales · 47,775 sh · avg $20.03 · $956,933
Loading xslF345X06/ownership.xml…